Probiotics in neurodegenerative disorders
Background:Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS), are associated with chronic neuroinflammation and gut microbiota dysbiosis. Increasing evidence suggests that modulation of the microbiota–gut–brain axis with probiotics may represent a novel therapeutic strategy. Aim:To summarize current evidence on the effects of probiotic supplementation in AD, PD, MS, and ALS, focusing on potential mechanisms of action and therapeutic outcomes. Material and methods: A review of scientific literature concerning the influence of gut microbiota on the nervous system through the microbiota-gut-brain axis was conducted. Clinical and preclinical studies evaluating the effectiveness of probiotic therapy in selected neurodegenerative diseases were analyzed. Results: Probiotic supplementation demonstrated beneficial effects across several neurodegenerative disorders. In AD, probiotics improved cognitive performance, reduced inflammatory markers, and attenuated oxidative stress. In PD, they alleviated gastrointestinal symptoms, improved bowel function, enhanced motor performance, and reduced systemic inflammation. In MS, probiotics decreased pro-inflammatory cytokine expression, promoted anti-inflammatory immune responses, and increased brain-derived neurotrophic factor levels. Experimental ALS studies indicated restoration of gut microbiota, improved intestinal barrier integrity, delayed disease progression, and prolonged survival in animal models. Conclusion: Probiotics demonstrate promising therapeutic potential in treating neurodegenerative diseases through modulation of gut microbiota and influence on the gut-brain axis. However, further clinical studies are necessary to confirm their clinical significance and biological effects.
Authors
- Zenon Paweł Czuba (ORCID: https://orcid.org/0000-0001-8216-4495)
- Łukasz Sędek (ORCID: https://orcid.org/0000-0001-9384-914X)
- Małgorzata Katra (ORCID: https://orcid.org/0009-0007-3772-3455)
- Rafał Szarek (ORCID: https://orcid.org/0009-0001-9118-0769)
- Mikołaj Szczęsny (ORCID: https://orcid.org/0009-0003-1010-9712)
- Bogumiła Szarek (ORCID: https://orcid.org/0000-0002-4760-3808)
Institutions
- Medical University of Silesia (PL)
- Independent Public Health Care Institution of the Ministry of the Interior and Administration in Krakow, Kraków, Poland (PL)
- Szpital Zakonu Bonifratrów św. Jana Grandego w Krakowie (PL)
Publication Details
- Journal
- Journal of Education Health and Sport
- Published
- 2026-11-16
- DOI
- https://doi.org/10.12775/jehs.2026.95.74001
- Primary Topic
- Probiotics and Fermented Foods
- Type
- article
- Field-Weighted Citation Impact
- 0.00